Back

Frailty is associated with suboptimal guideline-directed medical therapy in heart failure hospital admissions

11 May 2026 (13:38 - 14:55)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (1) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Alessandro Maggi

Brescia (Italy)

5 More presentations in this session

Presentation thumbnail
Impact of sacubitril/valsartan on lipid parameters in patients with heart failure with reduced ejection fraction
Doctor I. Aydin (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Efficacy and safety of intravenous sodium ferric gluconate complex in iron-deficient patients hospitalized for heart failure: a meta-analysis
Miss B. Tran (Debrecen, HU)
Abstract Slides
Presentation thumbnail
The role of Ivabradine in hospitalized acute decompensated heart failure patients: a single center retrospective study
Associate Professor S. AHMED (Ras Al Khaimah, AE)
Abstract Slides
Presentation thumbnail
The real-world use of benefit-unproven ARBs in HFrEF: clinical outcomes and prescription patterns
Assistant Professor J. Park (Busan, KR)
Abstract Slides
Presentation thumbnail
Exogenous tetrahydrobiopterin supplementation ameliorates heart failure with preserved ejection fraction by attenuating metabolic dysregulation and cardiac oxidative stress
Assistant Professor Y. Cai (Hung Hom, HK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (1)

The Event

Event poster

Heart Failure 2026

11 May 2026 13:38 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Navigating through heart failure device therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources